Explore BioCryst Pharmaceuticals, Inc.'s latest Form 8-K filed on February 24, 2025, detailing significant corporate developments crucial for investors and stakeholders.
Discover vital insights from BioCryst Pharmaceuticals' 8-K filing on January 13, 2025. Understand potential impacts on investors and market trends. Stock Symbol: BCRX.
Discover BioCryst Pharmaceuticals' latest 8-K filing detailing significant events on January 10, 2025. Stay informed on corporate changes and stock performance insights.
Explore BioCryst Pharmaceuticals' recent 8-K filing as of January 8, 2025, detailing significant financial events and stock-related disclosures. Stay informed on BCRX updates!